|
|
||||||||
Brief Report |
From Bethesda Family Medicine Residency Program (SEW, SJ); the E. Kenneth Hatton, MD, Institute for Research and Education (VG, AE, JM), Cincinnati, OH
Correspondence: Corresponding author: Scott E. Woods, MD, MPH, MEd, Associate Program Director, Bethesda Family Medicine Residency Program, 4411 Montgomery Road, Suite 200, Cincinnati, OH 45212 (E-mail: Liverdoctor{at}yahoo.com)
Objective: To prospectively assess if chromium levels are different in gestational diabetics than in nondiabetic pregnant women. Therapeutic options could exist if levels are different.
Methods: We conducted a 2-year prospective, gestational cohort study. The cohort included newly diagnosed pregnant patients. Two blood samples were taken, the first at consent, the second at the time of diabetes screening.
Results: Five hundred eighty patients entered the cohort. One hundred fifty-five were lost to follow up and 425 patients completed the study (396 nondiabetics and 29 diabetics). The patients with gestational diabetes were significantly older, with a family history of gestational diabetes, and were significantly more likely to have been a gestational diabetic in a previous pregnancy (P < 05). There was no significant difference between the 2 groups for chromium levels both at enrollment (0.15 ± 0.06 ng/mL vs 0.14 ± 0.03 ng/mL; P = .28) and during the second trimester (0.14 ± 0.06 ng/mL vs 0.14 ± 0.04 ng/mL; P = .82).
Conclusion: Serum chromium levels do not exhibit any significant variation between gestational diabetic women and nondiabetic women when assessed prospectively.
This article has been cited by other articles:
![]() |
M. A. Bowman, A. V. Neale, and P. Lupo Inside the March/April 2008 Issue and the Most Frequently-Read Articles in 2007 J Am Board Fam Med, March 1, 2008; 21(2): 87 - 90. [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |